Share This:
https://ntp.niehs.nih.gov/go/racb88105abs

Abstract for RACB88105

m-Nitrobenzoic Acid: Reproductive Toxicity in CD-1 Swiss Mice

CASRN: 121-92-6
Chemical Formula: C7H5NO4
Molecular Weight: 167.12
Report Date: June 1990

Abstract

The following abstract presents results of a study conducted by a contract laboratory for the National Toxicology Program. The findings were not evaluated in accordance with the levels of evidence for reproductive or developmental criteria established by NTP in March 2009. The findings and conclusions for this study should not be construed to represent the views of NTP or the U.S. Government.

Meta-Nitrobenzoic acid (MNB) is widely used in explosive and dyestuff industries, and also as a chemical intermediate in organic syntheses. In a 90 day pre-chronic study, both F344 rats and B6C3F1 mice exposed to high concentrations of MNB exhibited testicular atrophy and reduced sperm count. This RACB study using Swiss mice was performed as a follow-up to that original observation. Data from a two week dose-range-finding study (Task 1) were used to set exposure concentrations for the Task 2 continuous cohabitation study at 0.35, 0.75, and 1.5% in feed. Based on mean feed consumption and body weight, the estimated daily dosages were nearly equal to 0.5, 1.3, and 2.8 g/kg/d.

During Task 2, 4, 3, 2, and 3 animals died from causes ranging from lymphoma to ruptures to partner-inflicted wounds to a variety of infections. There was no clear relationship to MNB exposure. During Task 2, postpartum dam weights in the middle and high dose groups were nearly equal to 5-8% and nearly equal to 12-14% lower than controls, respectively. Male body weights were reduced only at the high dose, by nearly equal to 9%. Daily feed consumption was increased at the high dose, by nearly equal to 10%.

Reproductive performance was impaired during Task 2. Mice in the middle and high dose groups delivered nearly equal to 10% and 27% fewer pups/litter, respectively. At the high dose, there were 14% fewer litters/pair, and a 14% reduction in adjusted pup weight. In addition, the high dose group took from 5-7 days longer to deliver the third, fourth and fifth litters, a significant increase.

The last litter was reared by the dam until weaning. Pre-weaning pup mortality was increased at the high dose: ca. half the pups died before weaning, and the remaining pups weighed 30-40% less than their respective controls. The only effect at the middle dose was a 15% reduction in male pup weight at pnd 21.

After the last litter was reared, a crossover test (Task 3) was conducted with the control and high dose mice. There was a 33% reduction in the number of mated females who delivered a litter in the group containing treated females. Pup indices were reduced only in litters from treated females: they delivered 50% fewer pups/litter, and those pups weighed nearly equal to 10% less than their controls.

After the crossover pups were delivered and evaluated, the control and high dose F0 adults were killed and necropsied. Treated female body weight was reduced by 13%, and adjusted kidney weight was nearly equal to 7% lower in the 1.5% MNB females than in their controls. While there was no change in estrous cycle parameters or length, there were more cystic ovaries in the treated group (3/11) than in the controls (1/22). Male body weight at the high dose was reduced by nearly equal to 10% and adjusted liver weight was increased by nearly equal to 6%. Sperm indices were unchanged.

The F1 mice from all dose groups were reared on the same diet that was provided their parents, and cohabited within dose groups at nearly equal to pnd 74. At the high dose, there was a nearly equal to 20% reduction in live pup number, while adjusted pup weight was reduced in the middle and high dose groups by 13% and 21%, respectively.

After the F2 litters were delivered and evaluated, the F1 adults were killed and necropsied. Female body weight was reduced in the middle and high dose groups by 5% and 23%, respectively. Adjusted liver weight was increased by nearly equal to 12% at the high dose; estrous cycle parameters were unchanged across dose groups. Male body weight was reduced by 10% and 18% in the middle and high dose groups, respectively. Adjusted kidney weight was reduced by nearly equal to 10% at the high dose only. No significant treatment-related microscopic lesions were noted in the reproductive organs of these animals.

Thus, meta-nitrobenzoic acid reduced weight gain in adults and caused significant reproductive toxicity in both generations. The second generation was not clearly more affected than the first. The female appeared more sensitive than the male, and, though body weight was reduced, non-reproductive toxicities (organ weight changes, microscopic lesions) were not marked.

NTIS # PB90256058